Your browser doesn't support javascript.
loading
EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors.
Li, Dan; Guo, Xianling; Yang, Kun; Yang, Yuening; Zhou, Weilin; Huang, Yong; Liang, Xiao; Su, Jinhua; Jiang, Lin; Li, Jing; Fu, Maorong; He, Haixia; Yang, Jinrong; Shi, Huashan; Yang, Hanshuo; Tong, Aiping; Chen, Nianyong; Hu, Jiankun; Xu, Qing; Wei, Yu-Quan; Wang, Wei.
Afiliação
  • Li D; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Guo X; Department of Oncology, Shanghai Tenth Peoples' Hospital, Shanghai, China.
  • Yang K; Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Yang Y; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Zhou W; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Huang Y; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Liang X; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Su J; Department of Head and Neck Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Jiang L; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Li J; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Fu M; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • He H; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Yang J; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Shi H; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Yang H; Department of Radiation Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Tong A; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Chen N; Department of Hematology, Hematology Research Laboratory, West China Hospital, Sichuan University, Chengdu, China.
  • Hu J; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Xu Q; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Wei YQ; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Wang W; Department of Head and Neck Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Sci Adv ; 9(48): eadg9721, 2023 12.
Article em En | MEDLINE | ID: mdl-38039357
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Epiteliais e Glandulares / Receptores de Antígenos Quiméricos Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Epiteliais e Glandulares / Receptores de Antígenos Quiméricos Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article